Literature DB >> 10562974

Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

A H Tejani1, E K Sullivan, S R Alexander, R N Fine, W E Harmon, E C Kohaut.   

Abstract

We define delayed graft function (DGF) as the need for dialysis during the first post-transplant week. We analyzed 5272 transplants, of which 2486 were of living donor (LD) and 2786 were of cadaver donor (CD) origin. Twelve per cent (620/5272) of all patients developed DGF. Donor specific rates were 5.6% for LD and 19.1% for CD patients. Factors predictive of DGF in CD patients were: African-American race (25%), prolonged cold ischemia (24%), absence of T-cell induction antibody therapy and absence of HLA-DR matching. The relative risk (RR) for graft failure due to DGF was 6.02 (p < 0.001) in LD patients and 2.58 (p < 0.001) for CD recipients. Two-year graft survival (GS) in LD patients without DGF was 89.6%, compared to 41.6% for those with DGF (p < 0.001); in CD patients it was 80.2% and 49.5%, respectively (p < 0.001). Censoring for primary non-function, GS for LD patients with a functioning graft at 30 d post-transplant and no DGF was 91.5%, compared to 70.1% for those with DGF (p < 0.001); GS for CD patients was 83.8% and 68.7%, respectively (p < 0.001). However, when patients whose grafts had failed during the first year were censored no differences in GS were noted between patients with and without DGF for either LD or CD recipients. To determine whether DGF acts as an independent risk factor for graft failure, patients were segregated into four groups: rejection with DGF; rejection without DGF; DGF without rejection; and no DGF, no rejection. When these groups were compared DGF emerged as an independent risk factor for graft failure. This large study reviewing pediatric renal transplantation over 10 yr clearly delineates the role of DGF as a major risk factor for graft failure.

Entities:  

Mesh:

Year:  1999        PMID: 10562974     DOI: 10.1034/j.1399-3046.1999.00057.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  7 in total

1.  Immune function in healthy inner-city children.

Authors:  J A Bartlett; A R Goldklang; S J Schleifer; S E Keller
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

Authors:  Yingyos Avihingsanon; Naili Ma; Martha Pavlakis; W James Chon; Marc E Uknis; Anthony P Monaco; Christiane Ferran; Isaac Stillman; Asher D Schachter; Christina Mottley; Xin Xiao Zheng; Terry B Strom
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

Review 3.  Marked variation in the definition and diagnosis of delayed graft function: a systematic review.

Authors:  Sri G Yarlagadda; Steven G Coca; Amit X Garg; Mona Doshi; Emilio Poggio; Richard J Marcus; Chirag R Parikh
Journal:  Nephrol Dial Transplant       Date:  2008-04-11       Impact factor: 5.992

4.  Center-level variation in the development of delayed graft function after deceased donor kidney transplantation.

Authors:  Babak J Orandi; Nathan T James; Erin C Hall; Kyle J Van Arendonk; Jacqueline M Garonzik-Wang; Natasha Gupta; Robert A Montgomery; Niraj M Desai; Dorry L Segev
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

5.  Non-immunologic allograft loss in pediatric kidney transplant recipients.

Authors:  Isa F Ashoor; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

6.  Kidney NGAL is a novel early marker of acute injury following transplantation.

Authors:  Jaya Mishra; Qing Ma; Caitlin Kelly; Mark Mitsnefes; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2006-04-14       Impact factor: 3.714

7.  Identification of Molecular Markers of Delayed Graft Function Based on the Regulation of Biological Ageing.

Authors:  Dagmara McGuinness; Johannes Leierer; Olivier Shapter; Suhaib Mohammed; Marc Gingell-Littlejohn; David B Kingsmore; Ann-Margaret Little; Julia Kerschbaum; Stefan Schneeberger; Manuel Maglione; Silvio Nadalin; Sylvia Wagner; Alfred Königsrainer; Emma Aitken; Henry Whalen; Marc Clancy; Alex McConnachie; Christian Koppelstaetter; Karen S Stevenson; Paul G Shiels
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.